Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, May 23, 2024 | Back issues
Courthouse News Service Courthouse News Service

FTC Says Cephalon Cheated To Protect Drug

WASHINGTON (CN) - Cephalon illegally restrained commerce by buying off four generic competitors with more than $200 million to delay generic competition for its wakefulness drug, Provigil, until 2012, the FTC claims in Federal Court. Provigil's antitrust violations will cost consumers "hundreds of millions of dollars a year," the FTC says.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.